Cardiome Pharma Corp. (T:COM)

Business Focus: Biopharmaceuticals

This company is also listed in the United States as CRME on the NASDAQ. Click here to see if there are any SEC insider filings on insidertracking.com.
Log in or sign up for a free account to add this stock to your watch list.

Insider Chart - Past 6 Months

Latest 10 SEDI filings (by transaction date) for COM within the last 6 months ?
Amended Filing
As of 11:59pm ET May 27th, 2015
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/15 May 14/15 O'Shea, William James Direct Ownership Options 38 - Redemption, retraction, cancellation, repurchase -10,026 $8.23
Mar 30/15 Mar 27/15 Grant, Sheila Direct Ownership Common Shares 10 - Disposition in the public market -1,400 $10.64
Mar 31/15 Mar 26/15 Hunter, William L. Direct Ownership Units Restricted Share Units 56 - Grant of rights 39,306 $10.35
Mar 31/15 Mar 26/15 Hunter, William L. Direct Ownership Options 56 - Grant of rights 130,000 $10.35
Mar 31/15 Mar 26/15 Archibald, Jennifer Direct Ownership Units Restricted Share Units 56 - Grant of rights 9,714 $10.35
Mar 31/15 Mar 26/15 Archibald, Jennifer Direct Ownership Options 50 - Grant of options 32,700 $10.35
Mar 31/15 Mar 26/15 McMasters, David D. Direct Ownership Units Restricted Share Units 56 - Grant of rights 9,714 $10.35
Mar 31/15 Mar 26/15 McMasters, David D. Direct Ownership Options 50 - Grant of options 32,700 $10.35
Mar 31/15 Mar 26/15 Sachot, Hugues Direct Ownership Units Restricted Share Units 56 - Grant of rights 9,714 $10.35
Mar 31/15 Mar 26/15 Sachot, Hugues Direct Ownership Options 50 - Grant of options 32,700 $10.35
Cardiome Pharma Corp. Insider Report Only $20.00